Abstract | BACKGROUND: METHODS AND RESULTS: We retrospectively investigated the clinical characteristics of 278 continuous outpatients who received blood test including complete blood count and serum creatinine concentration (mean age, 69.9 ± 10.8 years; male, 68.7%). The frequency of anemia was 51% in patients receiving PPI and 19% in those not receiving PPI (chi-squared test, P<0.001). On multivariate analysis female sex (P<0.001), peripheral artery disease (P=0.003), PPI (P=0.003), low white blood cell count (P=0.004), old age (P=0.007), and low estimated glomerular filtration rate (P=0.010) were independently associated with low Hb. Among these patients, we investigated the change in Hb after the initiation of PPI in 36 patients for whom data on Hb level within 1 year before and within 1 year after the initiation of PPI were available. Mean decrease in Hb after the initiation of PPI was 0.38 ± 0.87 g/dl (95% confidence interval: -0.67 to -0.09 g/dl). CONCLUSIONS: Use of PPI was associated with anemia in Japanese cardiovascular outpatients.
|
Authors | Toshiyuki Shikata, Naoko Sasaki, Masahiro Ueda, Takeshi Kimura, Kanako Itohara, Masataka Sugahara, Miho Fukui, Eri Manabe, Tohru Masuyama, Takeshi Tsujino |
Journal | Circulation journal : official journal of the Japanese Circulation Society
(Circ J)
Vol. 79
Issue 1
Pg. 193-200
( 2015)
ISSN: 1347-4820 [Electronic] Japan |
PMID | 25392070
(Publication Type: Journal Article)
|
Chemical References |
- Hemoglobins
- Proton Pump Inhibitors
- Creatinine
|
Topics |
- Aged
- Aged, 80 and over
- Anemia
(blood, chemically induced, etiology)
- Blood Cell Count
- Body Mass Index
- Cardiovascular Diseases
(blood, epidemiology)
- Creatinine
(blood)
- Diabetes Mellitus
(epidemiology)
- Erythrocyte Indices
- Female
- Hemoglobins
(analysis)
- Humans
- Hyperlipidemias
(epidemiology)
- Hyperuricemia
(epidemiology)
- Iron Deficiencies
- Kidney Diseases
(blood, epidemiology)
- Male
- Outpatients
(statistics & numerical data)
- Peptic Ulcer Hemorrhage
(epidemiology, prevention & control)
- Peripheral Arterial Disease
(blood, epidemiology)
- Polypharmacy
- Proton Pump Inhibitors
(adverse effects, pharmacology, therapeutic use)
- Retrospective Studies
- Risk Factors
- Vitamin B Deficiency
(blood, chemically induced)
|